MedTrace Logo

Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty

NCT02920515 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 740

Last updated 2016-09-30

No results posted yet for this study

Summary

This is a prospective, multicentric, comparative, non-randomized interventional study in which subjects diagnosed with central precocious puberty (CPP) and early puberty (EP) were treated for 6 months to compare the effect with GnRHa and traditional Chinese medicines.

Conditions

  • Central Precocious Puberty

Interventions

DRUG

Triptorlin or Leuprorelin

Gonadotrophin releasing hormone agonists (GnRHa)

DRUG

Zhibo dihuang pills

Traditional Chinese Medicine

DRUG

Dabu ying pills

Traditional Chinese Medicine

Sponsors & Collaborators

  • Shanghai Children's Hospital

    collaborator OTHER

  • Shanghai Children's Medical Center

    collaborator OTHER

  • Xin Hua Hospital

    collaborator OTHER

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Pin Li, Dr · Shanghai Children's Hospital

  • Xuefan Gu, Dr · Xin Hua Hospital

  • Xiaodong Huang, Dr · Shanghai children's medicial Center

  • Fan Jiang, Dr · Shanghai children's medicial Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
14 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2015-08-31
Completion
2015-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02920515 on ClinicalTrials.gov